Elaine Shannon
Global Quality Officer
@takeda.com
Christophe Weber
Representative Director - President & CEO
@takeda.com
Julie Kim
CEO-Elect
@takeda.com
Laura Nocerino
Rare Business Unit Head
@takeda.com
Akiko Amakawa
Corporate Strategy Officer & CEO Chief of Staff
@takeda.com
Phil Rowlands
Head, Oncology Therapeutic Area Unit
@takeda.com
Teresa Bitetti
President, Global Oncology, Takeda
@takeda.com
Lauren Duprey
Chief Human Resources Officer
@takeda.com
Gabriele Ricci
Chief Data & Technology Officer
@takeda.com
Chris Arendt
Head, Oncology Drug Discovery Unit
@takeda.com
Andy Plump
President, R&D
@takeda.com
Christopher Morabito
Head, R&D, Plasma-Derived Therapies
@takeda.com
Milano Furuta
Director – Chief Financial Officer
@takeda.com
Sheelagh Cawley-Knopf
Head, R&D Global Portfolio Strategy
@takeda.com
Masami Iijima
Chair of the Board of Directors
@takeda.com
Asuka Miyabashira
President, Japan Pharma Business Unit
@takeda.com
Natalie Furney
Global General Counsel
@takeda.com
Sameh Rafla
General Manager
@takeda.com
Marcello Agosti
Global Business Development Officer
@takeda.com
Nicola Greenway
Chief Human Resources Officer
@takeda.com
Christophe Bianchi
President, Global Oncology Business Unit
@takeda.com
Rhonda Pacheco
President, U.S. Business Unit and U.S. Country Head
@takeda.com
Dan Curran
Head, Rare Disease Therapeutic Area Unit
@takeda.com
Ramy Riad
President, Plasma-Derived Therapies Business Unit
@takeda.com
Awny Farajallah
Chief Medical Officer
@takeda.com
Asit Parikh
Head, GI Therapeutic Area Unit
@takeda.com
Giles Platford
President, Plasma-Derived Therapies Business Unit
@takeda.com
Andrew S. Plump
Director - President, Research & Development
Anna Maria Bencini
Chairman of the Board and CEO
Elke Michiels
Ethics and Collaboration
@takeda.com
Lamia Masmoudi
Medical Affairs Director
@takeda.com
Rachael Brake
Global Program Leader, Oncology
@takeda.com
Carlos Soto
Covington Site Head
@takeda.com
Deborah Hartman
Global Program Leader, Neuroscience
@takeda.com